Advanced search×

Discovery of novel methanone derivatives acting as antimycobacterial agents.

J Enzyme Inhib Med Chem 26(6):890-4 (2011) PMID 21395486

A series of pyrazoline derivatives were synthesized and in vitro activity against Mycobacterium tuberculosis H37Rv was carried out. Among the synthesized compounds, compounds (4d) and (4f) 4-aminophenyl-3-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-ylmethanone and 4-aminophenyl-6,7-dimethoxy-3-phenyl-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-ylmethanone were found to be the most active agent against M. tuberculosis H37Rv with a minimum inhibitory concentration of 10 μg/mL.

DOI: 10.3109/14756366.2011.559945
Version: za2963e q8za7 q8zbd q8zc4 q8zdf q8ze7 q8zfd q8zg9

Similar articles you may find interesting…

  1. Advances in the development of hybrid anticancer drugs.

    Expert Opin Drug Discov (2013) PMID 23646979

    Hybrid anticancer drugs are of great therapeutic interests as they can potentially overcome most of the pharmacokinetic drawbacks encountered when using conventional anticancer drugs. In fact, the future of hybrid anticancer drugs is very bright for the discovery of highly potent and selective molec...
  2. Automated docking for novel drug discovery.

    Expert Opin Drug Discov (2013) PMID 23642085

    The volume of three-dimensional structural information of macromolecules and the number of computational tools to predict binding modes and affinities of molecular complexes are increasing daily. Molecular docking is a rational structural approach employed to predict thermodynamic parameters based o...
  3. Proteomic characterization of human platelet-derived microparticles.

    Anal Chim Acta (2013) PMID 23601281

    We used a shotgun proteomics approach by nanoHPLC separation followed by MS analysis on an LTQ Orbitrap XL. PMPs were produced from isolated platelets stimulated with adenosine diphosphate (ADP). We developed an analytical platform constituted by two different steps: in the first one we used a stand...